Abstract
Over the past two decades, public interest in the basic biological processes underlying the phenomenon of ageing has grown considerably. New developments in biotechnology and health maintenance programmes appear to be forging new relationships between biology, medicine and the lives of older people. A number of social scientists describe the process as the ‘biomedicalization of aging’. In this article, we argue that contemporary biogerontology, an important sub-field of gerontology that could be construed as the primary actor in the process of ‘biomedicalization’, should be regarded instead as advancing a critique of biomedicine. We then provide a genealogy of the critique and close the argument by pointing to sources of uncertainty within biogerontology, which should be taken into account in any further studies of the relationship between biology, medicine and the lives of older people.
Similar content being viewed by others
Notes
1 Defining biogerontology, especially in relation to the ‘anti-ageing’ movement and medicine, is fraught with difficulties and ambiguities (Fishman et al., 2008; Juengst et al., 2003), but we hope that the account we provide here goes some way toward clarifying differences.
2 The interview was conducted in the context of the ESRC funded project ‘Boundary work, normal ageing and brain pathology’.
References
Achenbaum A.W. (1995). Crossing frontiers: Gerontology emerges as a science. Cambridge: Cambridge UP.
Alliance for Aging Research (2005). The science of aging gracefully: Scientists and the public talk about aging research. URL (accessed March 2009): www.policyarchive.org/bitstream/handle/10207/5577/science_of_aging_gracefully.pdf.
Anon . (2008). ‘Interview with Robert Butler, M.D.’, Rejuvenation Research, 11, 977–980.
Ballenger J. (2006). Self, senility, and Alzheimer's Disease in modern America. Baltimore, MD: Johns Hopkins UP.
Bookstein F., & Achenbaum W.A. (1993). Aging as explanation: How scientific measurement can advance critical gerontology. In Cole T.R., Achenbaum W.A., Jakobi P., & Kastenbaum R. (Eds), Voices and visions of aging: Toward a critical gerontology, 20–43. New York: Springer.
Boltanski L., & Thévenot L. (1999). The sociology of critical capacity. European Journal of Social Theory, 2, 359–377.
Butler R.N. (1975). Why survive? Growing old in America. New York: Harper & Row.
Butler R.N. (1977). Research programs of the National Institute of Aging. Public Health Reports, 92, 3–8.
Butler R.N., Miller R.H., Perry D., Carnes B.A., Williams T.F., Cassel C. et al. (2008). New model of health promotion and disease prevention for the 21st century. British Medical Journal, 337, 399.
Canguilhem G. (1991). The normal and the pathological. New York: Zone Books.
Clarke A.E., Mamo L., Fishman J.R., Shim J.K., & Fosket J.R. (2003). Biomedicalization: Technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review, 68, 161–194.
Dawkins R. (1976). The selfish gene. Oxford: Oxford UP.
Estes C.L., & Binney E. (1989). The biomedicalization of aging: Dangers and dilemmas. Gerontologist, 29, 587–596.
Fishman J.R., Binstock R.H., & Lambrix M.A. (2008). Anti-aging science: The emergence, maintenance, and enhancement of a discipline. Journal of Aging Studies, 22, 295–303.
Fox P. (1989). From senility to Alzheimer's disease: The rise of the Alzheimer's disease movement. Milbank Quarterly, 57, 58–102.
Gaudillière J.-P. (2002). Inventer la biomédecine: La France, l'Amérique et la production des savoirs du vivant, 1945–1965. Paris: La Découverte.
Haber C. (1986). Geriatrics: A specialty in search of specialists. In Van Tassel D.D., & Stearns P.N. (Eds), The elderly in a bureaucratic world: The elderly, the experts, and the state in American history, 66–84. Westport, CT: Greenwood Press.
Haber C., & Gratton B. (1994). Old age and the search for security: An American social history. Bloomington: Indiana UP.
Hayflick L. (1974). The strategy of senescence. Gerontologist, 14, 37–45.
Hayflick L. (1994). How and why we age. New York: Ballantine.
Hirshbein L.D. (2000). ‘Normal’ old age, senility, and the American Geriatrics Society in the 1940s. Journal of the History of Medicine and Allied Sciences, 55, 337–362.
House of Lords (2006a). Science and Technology Committee: 6th Report. URL (accessed March 2009): www.publications.parliament.uk/pa/ld200506/ldselect/ldsctech/146/14603.htm
House of Lords (2006b). Science and Technology Committee: Memorandum by Professor Tom Kirkwood, Specialist Adviser to Sub-Committee. URL (accessed March 2009): www.parliament.the-stationery-office.com/pa/ld200506/ldselect/ldsctech/146/146we07.htm.
House of Lords (2005). Ageing: Scientific aspects. URL (accessed March 2009): www.publications.parliament.uk/pa/ld200506/ldselect/ldsctech/20/20i.pdf
Juengst E.T., Binstock R.H., Mehlman M., Post S.G., & Whitehouse P. (2003). Biogerontology, ‘anti-aging medicine,’ and the challenges of human enhancement, Hastings Center Report, 33(4): 21–30.
Kaufman S.R., Shim J.K., & Russ A.J. (2004). Revisiting the biomedicalization of aging: Clinical trends and ethical challenges. Gerontologist, 44, 731–738.
Keating P., & Cambrosio A. (2003). Bio-medical platforms: Realigning the normal and the pathological in late twentieth-century medicine. Cambridge, MA: MIT Press.
Kirkwood T. (1977). Evolution of ageing. Nature, 270, 301–304.
Kirkwood T. (1999). Time of our lives: The science of human aging. Oxford: Oxford UP.
Kirkwood T., & Austad S. (2000). Why do we age? Nature, 408, 233–238.
Landecker H. (2007). Culturing life: How cells became technologies. Cambridge, MA: Harvard UP.
Lockett B.A. (1983). Aging, politics, and research: Setting the federal agenda for research on aging. New York: Springer.
Martin M. (1995). Medical knowledge and medical practice: Geriatric medicine in the 1950s. Social History of Medicine, 8, 443–461.
May C., Rapley T., Moreira T., Finch T., & Heaven B. (2006). Technogovernance: Evidence, subjectivity, and the clinical encounter in primary care medicine. Social Science and Medicine, 62, 1022–1030.
Medawar P., & Medawar J. (1977). The life science: Current ideas of biology. London: Wildwood House.
Miller R. (2002). Extending life: Scientific prospects and political obstacles. Milbank Quarterly, 80, 155–174.
Moreira T. (2009). Truth and hope in drug development and evaluation in Alzheimer's Disease. In Ballenger J.F., Whitehouse P.J., Lyketsos C.G., Rabins P.V., & Karlawish J.H.T. (Eds), Treating dementia: Do we have a pill for it?, 210–230. Baltimore, MD: Johns Hopkins UP.
Moreira T., & Palladino P. (2005). Between truth and hope: Parkinson's disease, neural transplants and the self’, History of the Human Sciences, 3, 55–82.
Moreira T., & Palladino P. (2008). Squaring the curve: The anatomo-politics of ageing, life and death. Body & Society, 14, 21–47.
MORI (2006). Public consultation on ageing: Research into public attitudes towards BBSRC and MRC-funded research on ageing. URL (accessed March 2009): www.bbsrc.ac.uk/society/dialogue/attitude/ageing_mori_sri.pdf
Mykytyn C.E. (2008). Medicalizing the optimal: Anti-aging medicine and the quandary of intervention. Journal of Aging Studies, 22, 313–321.
Nesse R.M., & Williams G.C. (1996). Why we get sick: The new science of Darwinian medicine. New York: Vintage.
Olshansky J., Hayflick L., & Carnes B. (2002). Position statement on human aging. Journal of Gerontology Ser. A, 57, 292–297.
Oppenheimer G.M. (2005). Becoming the Framingham Study, 1947–1950. American Journal of Public Health, 95, 602–610.
Park H.W. (2008). Edmund Vincent Cowdry and the making of gerontology as a multidisciplinary scientific field in the United States. Journal of the History of Biology, 41, 529–572.
Porter D. (1997). The decline of social medicine in Britain in the 1960s. In Porter D. (Ed.), Social medicine and medical sociology in the twentieth century, 97–119. Amsterdam: Rodopi.
Rothstein W.G. (2003). Public health and the risk factor: A history of an uneven medical revolution. Rochester, NY: University of Rochester Press
Rose N. (2007). The politics of life itself: Biomedicine, power, and subjectivity in the twenty-first century. Princeton, NJ: Princeton UP.
Shock N.W. (1956). Some physiological aspects of aging in man. Bulletin of the New York Academy of Medicine, 32, 268–283.
Shock N.W. (1961). Public health and the aging population. Public Health Reports, 76, 1023–1027.
Stewart J. (2008). The political economy of the British National Health Service, 1945–1975: Opportunities and constraints? Medical History, 52, 453–470.
Thane P. (2000). Old age in English history: Past experiences, present issues. Oxford: Oxford UP.
White House Conference on Aging (2005). Executive summary. URL (accessed March 2009): www.whcoa.gov/Final_Report_June_14nowater.pdf
Wolstenholme G.E.W., & Cameron M.P. (Eds) (1955). Ciba Foundation Colloquia on Ageing, vol. 1: General aspects. Boston, MA: Little, Brown.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moreira, T., Palladino, P. Ageing between Gerontology and Biomedicine. BioSocieties 4, 349–365 (2009). https://doi.org/10.1017/S1745855209990305
Published:
Issue Date:
DOI: https://doi.org/10.1017/S1745855209990305